CDK5 positively regulates Notch1 signaling in pancreatic cancer cells by phosphorylation

The marked overexpression of cyclin‐dependent kinase 5 (CDK5) or Notch1 receptor, which plays critical roles in pancreatic ductal adenocarcinoma (PDAC) development, has been detected in numerous PDAC cell lines and tissues. Although, a previous study has demonstrated that CDK5 inhibition disrupts Notch1 functions in human umbilical vein endothelial cells, the mechanism underlying Notch1 activation regulated by CDK5 remains unclear. Herein, we identified a physical interaction between CDK5 and Notch1 in PDAC cells, with the Notch1 peptide phosphorylated by CDK5/p25 kinase. CDK5 blockade resulted in the profound inhibition of Notch signaling. Accordingly, CDK5 inhibition sensitized PDAC cell proliferation and migration following Notch inhibition. In conclusion, CDK5 positively regulates Notch1 function via phosphorylation, which in turn promotes cell proliferation and migration. The combinational inhibition of CDK5 and Notch signaling may be an effective strategy in the treatment of PDAC.

• Publication year

  2021

• Venue

  Cancer Medicine

• Publication date

  2021-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cam4.3916PMID 33960694PMCID 8178504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A kinase of many talents: non-neuronal functions of CDK5 in development and disease

  2020cited by this paper
• Overview of Basic Mechanisms of Notch Signaling in Development and Disease.

  2020cited by this paper
• Cyclin-Dependent Kinase 5 (CDK5)-Mediated Phosphorylation of Upstream Stimulatory Factor 2 (USF2) Contributes to Carcinogenesis

  2019cited by this paper
• Mechanisms of Notch signaling: a simple logic deployed in time and space

  2019cited by this paper
• Synthesis and Anticancer Activity Evaluation of Novel Phenanthridine Derivatives

  2019cited by this paper
• Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges

  2018cited by this paper
• Fluorogenic Peptide Substrate for Quantification of Bacterial Enzyme Activities

  2017cited by this paper
• Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

  2017cited by this paper
• Inhibition of Cdk5 induces cell death of tumor-initiating cells

  2017cited by this paper
• Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

  2017cited by this paper
• Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome

  2017cited by this paper
• Cdk5 Regulation of the GRAB-Mediated Rab8-Rab11 Cascade in Axon Outgrowth

  2017cited by this paper
• GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

  2017cited by this paper
• Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis

  2016cited by this paper
• The Emerging Role of Cdk5 in Cancer.

  2016cited by this paper
• Cdk5 regulation of the GRAB-mediated Rab8-Rab11 cascade in axon outgrowth.

  2016cited by this paper
• Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.

  2015cited by this paper
• Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models

  2015cited by this paper
• Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

  2015cited by this paper
• From fly wings to targeted cancer therapies: a centennial for notch signaling.

  2014cited by this paper
• Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

  2014cited by this paper
• Glycogen synthase kinase 3-β phosphorylates novel S/T-P-S/T domains in Notch1 intracellular domain and induces its nuclear localization.

  2012cited by this paper
• The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells

  2012cited by this paper
• Cyclin-Dependent Kinase 5 Is Amplified and Overexpressed in Pancreatic Cancer and Activated by Mutant K-Ras

  2011cited by this paper
• Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

  2011cited by this paper
• Hierarchical Phosphorylation within the Ankyrin Repeat Domain Defines a Phosphoregulatory Loop That Regulates Notch Transcriptional Activity*

  2011cited by this paper
• Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.

  2010cited by this paper
• Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer

  2009cited by this paper
• Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

  2004cited by this paper
• The Cdk5‐p35 kinase associates with the Golgi apparatus and regulates membrane traffic

  2001cited by this paper
• Two Distinct Notch1 Mutant Alleles Are Involved in the Induction of T-Cell Leukemia in c-myc Transgenic Mice

  2000cited by this paper
• The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.

  1996cited by this paper

• The Duality of Cdk5: A Master Regulator in Neurodevelopment and a Hijacked Oncogene in Cancer

  2025cites this paper
• Deubiquitinase USP5 promotes acute myeloid leukemia through C2CD5 stabilization and PI3K/AKT/mTOR/HIF-1α-driven glycolysis.

  2025cites this paper
• Notch signaling pathway in pancreatic tumorigenesis.

  2023cites this paper
• Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors

  2021cites this paper
• GSK3β Interacts With CRMP2 and Notch1 and Controls T-Cell Motility

  2021cites this paper